373 related articles for article (PubMed ID: 8425564)
1. Potentiation of myeloid colony-formation in bone marrow of intact and neonatally thymectomized mice by the thymic hormone THF-gamma 2.
Pecht M; Lourie S; Burstein Y; Zipori D; Trainin N
Exp Hematol; 1993 Feb; 21(2):277-82. PubMed ID: 8425564
[TBL] [Abstract][Full Text] [Related]
2. THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice.
Umiel T; Pecht M; Trainin N
J Biol Response Mod; 1984 Aug; 3(4):423-34. PubMed ID: 6332883
[TBL] [Abstract][Full Text] [Related]
3. Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy.
Ophir R; Pecht M; Keisari Y; Rashid G; Lourie S; Meshorer A; Ben-Efraim S; Trainin N; Burstein Y
Immunopharmacol Immunotoxicol; 1996 May; 18(2):209-36. PubMed ID: 8771368
[TBL] [Abstract][Full Text] [Related]
4. Indirect stimulation of hemopoiesis by hemoregulatory peptide (HP5b) dimer in murine long-term bone marrow cultures.
Veiby OP; Løvhaug D; Fjerdingstad H; Engelsen SJ
Exp Hematol; 1992 Feb; 20(2):192-5. PubMed ID: 1544388
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
6. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
7. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
[TBL] [Abstract][Full Text] [Related]
8. Differences in in vitro proliferative responsiveness to granulocyte colony-stimulating factor and interleukin 2 of bone marrow cells from mice treated with chemotherapeutic drugs.
Mizushima Y; Morikage T; Yano S
Cancer Res; 1990 Mar; 50(6):1847-52. PubMed ID: 1689612
[TBL] [Abstract][Full Text] [Related]
9. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
[TBL] [Abstract][Full Text] [Related]
10. The role of a thymus humoral factor in the proliferation of bone marrow CFU-S from thymectomized mice.
Zipori D; Trainin N
Exp Hematol; 1975 Nov; 3(6):389-98. PubMed ID: 1104372
[TBL] [Abstract][Full Text] [Related]
11. [Differentiation characteristics of circulating and bone marrow hematopoietic stem cells and the effect of thymus factors].
Popov BV; Ergakova EV
Biull Eksp Biol Med; 1985 May; 99(5):610-3. PubMed ID: 3839146
[TBL] [Abstract][Full Text] [Related]
12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
14. Impaired radioprotective capacity and reduced proliferative rate of bone marrow from neonatally thymectomized mice;
Zipori D; Trainin N
Exp Hematol; 1975 Jan; 3(1):1-11. PubMed ID: 1097261
[TBL] [Abstract][Full Text] [Related]
15. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
[TBL] [Abstract][Full Text] [Related]
16. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME; Wepsic HT
Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
[TBL] [Abstract][Full Text] [Related]
17. The mast cell-committed progenitor. In vitro generation of committed progenitors from bone marrow.
Ashman RI; Jarboe DL; Conrad DH; Huff TF
J Immunol; 1991 Jan; 146(1):211-6. PubMed ID: 1898599
[TBL] [Abstract][Full Text] [Related]
18. Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor.
Umiel T; Trainin N
Eur J Immunol; 1975 Feb; 5(2):85-8. PubMed ID: 135681
[TBL] [Abstract][Full Text] [Related]
19. Effect of thymic hormone on the response of different lymphoid cell populations to T mitogens.
Rotter V; Trainin N
Isr J Med Sci; 1977 Apr; 13(4):363-70. PubMed ID: 301520
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE
Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
